Variant report
Variant | rs28407129 |
---|---|
Chromosome Location | chr14:104396669-104396670 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:22)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:22 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | NR2F2 | chr14:104396413-104397073 | MCF-7 | breast: | n/a | n/a |
2 | FOSL2 | chr14:104396556-104396910 | HepG2 | liver: | n/a | n/a |
3 | TCF7L2 | chr14:104396660-104396840 | Hela-S3 | cervix: | n/a | n/a |
4 | GATA3 | chr14:104396445-104397093 | MCF-7 | breast: | n/a | n/a |
5 | NR2F2 | chr14:104396474-104397099 | MCF-7 | breast: | n/a | n/a |
6 | FOSL2 | chr14:104396602-104396895 | HepG2 | liver: | n/a | n/a |
7 | ESR1 | chr14:104396623-104396899 | ECC-1 | luminal epithelium: | n/a | chr14:104396732-104396747 |
8 | ESR1 | chr14:104396594-104396992 | ECC-1 | luminal epithelium: | n/a | chr14:104396732-104396747 |
9 | JUND | chr14:104396646-104396893 | HepG2 | liver: | n/a | n/a |
10 | CEBPB | chr14:104396376-104397128 | MCF-7 | breast: | n/a | chr14:104396944-104396956 |
11 | EP300 | chr14:104396513-104396943 | MCF-7 | breast: | n/a | chr14:104396812-104396826 |
12 | ESR1 | chr14:104396545-104396956 | T-47D | breast: | n/a | chr14:104396732-104396747 |
13 | ESR1 | chr14:104396501-104396851 | ECC-1 | luminal epithelium: | n/a | chr14:104396732-104396747 |
14 | FOS | chr14:104396666-104396924 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | TCF7L2 | chr14:104396650-104397025 | MCF-7 | breast: | n/a | n/a |
16 | EP300 | chr14:104396501-104397114 | MCF-7 | breast: | n/a | chr14:104396812-104396826 |
17 | FOS | chr14:104396612-104396947 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOSL2 | chr14:104396500-104397065 | MCF-7 | breast: | n/a | n/a |
19 | ESR1 | chr14:104396641-104396938 | T-47D | breast: | n/a | chr14:104396732-104396747 |
20 | ESR1 | chr14:104396600-104396891 | ECC-1 | luminal epithelium: | n/a | chr14:104396732-104396747 |
21 | ESR1 | chr14:104396644-104396940 | ECC-1 | luminal epithelium: | n/a | chr14:104396732-104396747 |
22 | STAT3 | chr14:104396587-104396889 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:104159423..104160385-chr14:104396350..104397254,2 | MCF-7 | breast: | |
2 | chr14:104391843..104393363-chr14:104396413..104398370,2 | K562 | blood: | |
3 | chr14:104385710..104388983-chr14:104393675..104397966,4 | MCF-7 | breast: | |
4 | chr14:104395726..104398249-chr14:104421446..104423004,2 | K562 | blood: | |
5 | chr14:104393603..104397064-chr14:104407702..104410726,3 | K562 | blood: | |
6 | chr14:104387945..104390196-chr14:104396396..104397958,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
C14orf2 | TF binding region |
ENSG00000156411 | Chromatin interaction |
ENSG00000227729 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10129730 | 0.89[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs10131031 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs10131231 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs10137889 | 0.84[AMR][1000 genomes] |
rs10139210 | 0.84[AMR][1000 genomes] |
rs10142365 | 0.89[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs10149898 | 0.84[AMR][1000 genomes] |
rs12437404 | 0.90[ASN][1000 genomes] |
rs17101922 | 1.00[ASN][1000 genomes] |
rs17101932 | 1.00[EUR][1000 genomes] |
rs1951580 | 1.00[EUR][1000 genomes] |
rs1951587 | 1.00[EUR][1000 genomes] |
rs2295662 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs28432266 | 0.83[EUR][1000 genomes] |
rs28439019 | 0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs28493894 | 1.00[ASN][1000 genomes] |
rs28563863 | 0.89[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs34606901 | 1.00[ASN][1000 genomes] |
rs45471291 | 1.00[EUR][1000 genomes] |
rs45540638 | 1.00[EUR][1000 genomes] |
rs4900603 | 0.82[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4906384 | 1.00[ASN][1000 genomes] |
rs4906386 | 1.00[ASN][1000 genomes] |
rs4906388 | 0.84[AMR][1000 genomes] |
rs55920546 | 0.90[ASN][1000 genomes] |
rs56817754 | 1.00[ASN][1000 genomes] |
rs57047619 | 1.00[EUR][1000 genomes] |
rs57711557 | 1.00[EUR][1000 genomes] |
rs58071582 | 0.98[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs58557120 | 1.00[EUR][1000 genomes] |
rs58701300 | 0.90[ASN][1000 genomes] |
rs59838226 | 0.84[AMR][1000 genomes] |
rs59945383 | 1.00[EUR][1000 genomes] |
rs60080575 | 0.86[EUR][1000 genomes] |
rs60532123 | 1.00[EUR][1000 genomes] |
rs61451840 | 1.00[EUR][1000 genomes] |
rs6576015 | 0.86[EUR][1000 genomes] |
rs7144445 | 1.00[EUR][1000 genomes] |
rs7156752 | 1.00[EUR][1000 genomes] |
rs7157034 | 0.86[EUR][1000 genomes] |
rs7158035 | 0.86[EUR][1000 genomes] |
rs74086761 | 0.89[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs74086762 | 0.90[AFR][1000 genomes];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs74086783 | 0.84[AMR][1000 genomes] |
rs74089114 | 0.86[EUR][1000 genomes] |
rs8004485 | 0.80[AMR][1000 genomes] |
rs8009847 | 1.00[ASN][1000 genomes] |
rs8020110 | 0.87[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs8020476 | 0.86[EUR][1000 genomes] |
rs8021647 | 0.86[EUR][1000 genomes] |
rs8022184 | 0.86[EUR][1000 genomes] |
rs8022769 | 1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1045162 | chr14:104140525-104594841 | Flanking Active TSS Strong transcription Bivalent Enhancer Enhancers Active TSS Weak transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 87 gene(s) | inside rSNPs | diseases |
2 | nsv542204 | chr14:104140525-104594841 | Active TSS Enhancers Strong transcription Weak transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 87 gene(s) | inside rSNPs | diseases |
3 | esv2758368 | chr14:104147525-104412813 | Active TSS Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
4 | esv2760013 | chr14:104147525-104412813 | Enhancers Genic enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
5 | nsv902318 | chr14:104255083-104464809 | Active TSS Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 30 gene(s) | inside rSNPs | diseases |
6 | nsv902319 | chr14:104255083-104620077 | Weak transcription Enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 64 gene(s) | inside rSNPs | diseases |
7 | nsv1048353 | chr14:104361402-104483286 | Flanking Active TSS Active TSS Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
8 | nsv902322 | chr14:104365310-104464809 | Strong transcription Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
9 | nsv902323 | chr14:104381687-104464809 | Weak transcription Flanking Active TSS Active TSS Enhancers Strong transcription Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:104394600-104398200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr14:104395000-104401200 | Weak transcription | Spleen | Spleen |
3 | chr14:104395400-104399400 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr14:104395600-104397200 | Enhancers | HepG2 | liver |
5 | chr14:104395600-104398200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr14:104396200-104397000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
7 | chr14:104396200-104397200 | Enhancers | Primary B cells from cord blood | blood |
8 | chr14:104396200-104399800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
9 | chr14:104396600-104399400 | Weak transcription | Hela-S3 | cervix |
10 | chr14:104396600-104400600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |